Susan Wagland

As Clinical Trials Manager in Oxford Trauma Group I am responsible for day-to-day management of clinical trials:

• UKSTAR Study which is in recruitment;
• PATH-2 Study which has met its recruitment target and is in follow-up;
• AIM Trial, which has been published and is providing further data for analysis.

In UKSTAR we want to know whether patients with Achilles tendon ruptures treated non-surgically have a better outcome depending on whether they are immobilised in a plaster cast or an orthopaedic brace (walking boot). The PATH-2 study is investigating the effect of platelet rich plasma (PRP) as a non-surgical treatment for Achilles tendon ruptures, and the AIM Trial tested a new casting technique for ankle fractures treated without surgery. 

I have two years’ experience of clinical trial management, and prior to working for the University, I spent 15 years in the IT industry, and specialised in project management, data quality and release management. I have also worked in University administration.

During my scientific training, I worked on breast cancer and gained a PhD from Brunel University London in Biology and Biochemistry Research. I also hold a BSc (Hons) in Life Sciences from the Open University and a MSc from Brunel in Molecular Medicine with Cancer Research.